Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | RSS
The creator of TheActiveSurveillor.com, Howard Wolinsky was a medical writer for the Chicago Sun-Times for nearly thirty years and a regular contributor to MedPage Today and Medscape. When he was diagnosed with Gleason 6 (now also called GG1) prostate cancer he stepped back and said “No thanks” as he felt he was being rushed to choose a radical treatment option. Fourteen years down the road from his cancer diagnosis, he is one of the country’s most passionate voices for active surveillance as a first (and possibly forever) step as a response to indolent/favorable diagnoses of prostate cancer.
Besides being one of the country’s foremost prostate cancer advocates, Howard is also a full-time student (at age 77) in the University of Illinois – Chicago’s School of Public Health, one of the top-ranked Public Health grad programs in the U.S.
Program Notes
Links for Howard Wolinsky
- Howard Wolinsky on LinkedIn: linkedin.com/in/howardwolinsky
- Subscribe to The Active Surveillor: https://howardwolinsky.substack.com/
- Howard’s story in STAT News: https://www.statnews.com/2022/01/11/active-surveillance-for-prostate-cancer-the-gift-that-keeps-on-giving/
- How Wolinsky became an advocate: https://www.medpagetoday.com/hematologyoncology/prostatecancer/63251
Links for Active Surveillance
- Feature on Active Surveillance in the New York Times: https://www.nytimes.com/2020/03/02/well/live/before-prostate-surgery-consider-active-surveillance.html
- Most men with low-risk prostate cancer now opt for acttive surveillance. or monitoring: https://www.medscape.com/viewarticle/974009
- More than 60% of U.S. men with low-risk prostate cancer are now opting for active surveillance or monitoring: https://www.medscape.com/viewarticle/974009
Additional Links for Prostate Cancer
- Understanding why Secretary Austin wanted to keep his cancer a secret, but how he can help other patients by opening up: https://www.medpagetoday.com/special-reports/apatientsjourney/108309
- The risks of transrectal biopsies: https://www.medpagetoday.com/special-reports/apatientsjourney/92201
- The debate between transrectal and transperineal prostate biopsy methods: https://www.medscape.com/viewarticle/991496
- Is low-risk disease really prostate cancer? https://www.medpagetoday.com/special-reports/apatientsjourney/90601
The Stay in the Game podcast is sponsored by Cancer Health – online at cancerhealth.com.
Cancer Health empowers people living with prostate cancer and other cancers to actively manage and advocate for their care and improve their overall health. Launched in 2017, cancerhealth.com provides accessible information about treatment and quality of life for people with cancer and their loved ones, along with information about cancer prevention and health policy.
Episode Transcript
The episode transcript will be posted here when it becomes available.
